Proteomics International Laboratories (ASX:PIQ) Revenue : A$0.58 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Proteomics International Laboratories Revenue?

Proteomics International Laboratories's revenue for the six months ended in Dec. 2023 was A$0.62 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.58 Mil. Proteomics International Laboratories's Revenue per Share for the six months ended in Dec. 2023 was A$0.01. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.01.

Warning Sign:

Proteomics International Laboratories Ltd revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of Proteomics International Laboratories was -66.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was -27.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was -17.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 9 years, Proteomics International Laboratories's highest 3-Year average Revenue per Share Growth Rate was 4.00% per year. The lowest was -27.90% per year. And the median was -7.10% per year.

Proteomics International Laboratories Revenue Historical Data

The historical data trend for Proteomics International Laboratories's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proteomics International Laboratories Revenue Chart

Proteomics International Laboratories Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Revenue

Get a 7-Day Free Trial

1.47

1.42

1.31

1.49

0.73

Proteomics International Laboratories Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Revenue	Get a 7-Day Free Trial													0.65	0.84	0.77	-0.04	0.62

Competitive Comparison of Proteomics International Laboratories's Revenue

For the Biotechnology subindustry, Proteomics International Laboratories's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Proteomics International Laboratories's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Proteomics International Laboratories's Revenue distribution charts can be found below:

* The bar in red indicates where Proteomics International Laboratories's Revenue falls into.

Proteomics International Laboratories Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.58 Mil.

Proteomics International Laboratories (ASX:PIQ) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Proteomics International Laboratories Revenue Related Terms

Thank you for viewing the detailed overview of Proteomics International Laboratories's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Proteomics International Laboratories (ASX:PIQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Proteomics International Laboratories Ltd (ASX:PIQ) » Definitions » Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Verdun Street, QEII Medical Centre, QQ Block, Nedlands, Perth, WA, AUS, 6009

Website

https://www.proteomics.com.au

Proteomics International Laboratories Ltd is a biological research and drug discovery company. The company specializes in the area of proteomics which is the industrial-scale study of the structure and function of proteins. Its operations are divided into PromarkerD which targets the diabetes epidemic and is a predictive diagnostic test for diabetic kidney disease, a progressive disorder found in one in three adults with diabetes; its proprietary biomarker discovery platform called Promarker, which searches for protein fingerprints in a sample; and Analytical Services that are specialist contract research focusing on biosimilars quality control and pharmacokinetic testing for clinical trials.

Proteomics International Laboratories (ASX:PIQ) Headlines

No Headlines